Ads
related to: roche ihc catalog- Special Stains Kits
High-quality RTU stain kits
enable consistent special stains.
- H&E Reagents
Explore our portfolio of
ready-to-use H&E reagents.
- Dako Omnis
A fully automated IHC & ISH
platform for faster diagnosis.
- Dako CoverStainer
Automate H&E staining with
Dako CoverStainer.
- Special Stains Kits
Search results
Results From The WOW.Com Content Network
Ventana Medical Systems, Inc. was a medical device company that develops, manufactures, and markets instrument reagent systems that automate tissue and slide staining in anatomic pathology laboratories.
Chromogenic in situ hybridization (CISH) is a cytogenetic technique that combines the chromogenic signal detection method of immunohistochemistry (IHC) techniques with in situ hybridization. [1] [2] It was developed around the year 2000 as an alternative to fluorescence in situ hybridization (FISH) for detection of HER-2/neu oncogene ...
Roche acquired Syntex in 1994, and Chugai Pharmaceuticals in 2002. Oseltamivir an antiviral drug used to combat influenza. Roche is the only drug company authorized to manufacture the drug, which was discovered by Gilead Sciences. Roche purchased the rights to the drug in 1996, and in 2005, settled a royalty dispute, agreeing to pay Gilead ...
Immunohistochemistry can be performed on tissue that has been fixed and embedded in paraffin, but also cryopreservated (frozen) tissue.Based on the way the tissue is preserved, there are different steps to prepare the tissue for immunohistochemistry, but the general method includes proper fixation, antigen retrieval incubation with primary antibody, then incubation with secondary antibody.
The immunohistochemistry (IHC) test is a laboratory method that detects antibodies of prions (mis-shapen proteins thought to transmit bovine spongiform encephalopathy, BSE or mad cow disease) by exposing a brain sample to a stain that appears as a specific color under a microscope.
Roche Applied Science was founded in 1859 as Boehringer Mannheim, a developer of rare chemicals and pharmaceuticals. In the 1950s, the bioreagents product line was developed according to the company’s own needs in diagnostics research.
Syntex agreed to be acquired by the Roche group in May 1994. [6] After the acquisition closed, Roche downsized Syntex's research and development facilities in the Stanford Research Park and finally shut down what was left of Syntex in September 2008. [7] In 2011, VMware moved into the former Syntex campus in Palo Alto. [8]
In 2018, Roche acquired Foundation Medicine (via acquisition of the remaining 42.5% of Foundation Medicine for $2.4 billion), and currently operates it as a subsidiary. [ 12 ] [ 13 ] Guardant Health sued Foundation Medicine over patents in 2019–2020.